Increased Mean Platelet Volume in Deep Vein Thrombosis Patients With Cancer

Cemil Bilir, Huseyin Engin, Filiz Bilir

Abstract


Background: Patients who have malignancy have an increased risk of thromboembolism. Thromboembolic events occur in 4-20% of cancer patients. Mean platelet volume (MPV) is a machine-calculated measurement of platelet size from the blood that is usually reported in the blood tests as part of the CBC. In this study, we aimed to determine whether there is any relationship between MPV and DVT in cancer patients.

Methods: Outpatient oncology clinic records were searched between the period of 2006 and 2012 and 77 cancer patients with acute DVT were enrolled into the study.

Results: There were no statistically significant differences between the groups with regard to the age, gender, and laboratory parameters except MPV. MPV values were significantly higher in patients with DVT (8.6 ± 1.3 vs 7.7 ± 0.7, P < 0.001). The most common cancer types were colorectal, gynecologic and breast cancer in DVT patients. In the DVT group 46% of cancer was adenocarcinoma.

Conclusion: We have shown that MPV was significantly elevated in cancer patients with DVT compared to the cancer patients without DVT. Chemotherapy is one of the major risk factor for DVT in cancer patients. Chemotherapy regimens may increase MPV and so might trigger thromboembolism in cancer patients. Being metastatic or nonmetastatic is not a risk factor for increased MPV.




doi: http://dx.doi.org/10.4021/jh85w


Keywords


Mean platelet volume; Deep vein thrombosis; Cancer

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.

IMPORTANT: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!